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INTRODUCTION
I n the not too distant past, the 'immune system' was viewed as a complex set of cellular and molecular processes that protect us against pathogensfrom viruses and bacteria to parasitic worms. It is now clear that the cellular and molecular processes that make up our 'immune system' are also crucial to normal brain development and the formation of neural circuits. It is also becoming increasingly evident that the immune system plays a key role in the pathobiology of a number of neuropsychiatric and neurodegenerative disorders. This review summarizes the currently available literature across multiple domains and highlights how a deeper understanding of neuroimmunology is transforming the field of neuropsychiatry. A hallmark of this emerging area of science is the vast complexity of the nervous and immune systems and how interconnected they are with one another.
METHODS
This review article summarizes information assembled from a number of publications and systematic reviews of the scientific literature and is focused on the interface between the immune and nervous systems from early embryonic development through adolescence and adulthood. This includes the importance of the on-going "cross-talk" between the two systems, as it relates to the emergence of neurodevelopmental and neuropsychiatric disorders. Examples of summarized literature include, a special issue of Science magazine on 'Brain Development' published in October 2018 1 . Other examples include the articles published in a recent special issue of Biological Psychiatry on 'Prenatal programming of neuropsychiatric disorders across the lifespan' that was published earlier this year in January 2019 2 . The content of earlier special issues of Science, Biological Psychiatry and Brain Research were also reviewed [3] [4] [5] [6] . Additional review articles were accessed in PubMed by linking terms related to immunobiology with specific neuropsychiatric and neurodevelopmental disorders including Autism Spectrum Disorder (ASD), schizophrenia, obsessive-compulsive disorder (OCD), Tourette syndrome (TS), attention deficit hyperactivity disorder (ADHD), depression and mood disorders among others. In addition, PubMed searches were performed using key words and phrases that included: microglia, innate immune system, adaptive immune system, cytokines, maternal immune activation (MIA), neuro-immune network hypothesis, microbiota, microbiome, and the 'gut-brain axis'.
RESULTS
The emerging knowledge concerning the role that the immune system plays in specific neurodevelopmental and neuropsychiatric disorders, and several related topics are highlighted. They include: (i) microglia and the role of the immune system in early brain development; (ii) genetic determinants of immune function; (iii) stress, neuroinflammation, maternal immune activation (MIA) and the neuro-immune network hypothesis; and (iv) the microbiome and 'gut-brain axis.'
Microglia and the role of the immune system in normal brain development and neuropsychiatric disorders
Recent advances in our understanding of normal brain development highlight the important role played by the microglia [7] [8] [9] [10] [11] . Microglia are the resident macrophage population of the central nervous system (CNS). They originate from the yolk sac that colonizes the embryonic human CNS from as early as the 4th week of gestation and they constitute 5-15% of the cells in the CNS 12 . Microglia are not only among the first immune sentinels of infection, but they are also involved in early brain development. Initially, they were recognized as critical players in sculpting neuronal connectivity in the developing brain through synaptic pruning [13] [14] [15] . In addition to sculpting synaptic connectivity, emerging data show that microglia enter the embryonic brain before the differentiation of other CNS cell types and are critical regulators of early brain development, including regulating the number and maturation of neural precursors and other resident CNS cell types 12, 13 . Based on preliminary studies in adult mice, it appears that migrating microglia develop region-specific and sex-specific features, including the suggestion that female microglia are neuroprotective while male microglia are pro-inflammatory in character 14 . Microglia have also been shown to relay crucial information from the periphery to the CNS, including signals derived from the microbiota 16 . These findings underscore the importance of studying neurodevelopment as part of a broader framework that considers nervous system interactions with microglia and the immune system in a 'whole-body' context.
Evidence from human studies suggests that microglia are dysfunctional in at least a subset of individuals with neuropsychiatric disorders, as well as in neurodegenerative disorders such as Alzheimer's disease and chronic pain 17 . The range of neuropsychiatric disorders associated with at least some evidence of microglia dysfunction is broad and the list includes: Autism Spectrum Disorder (ASD), schizophrenia, bipolar disorder, major depression, OCD, and Tourette syndrome (TS) [17] [18] [19] [20] [21] . For example, postmortem studies of brain tissue from a small number of individuals with ASD have documented altered numbers of microglia in the dorsolateral prefrontal cortex [22] [23] [24] . Whole transcriptional analyses of postmortem brain tissue have also found that some individuals with ASD have altered expression of microglia-specific genes 25, 26 . Similar findings in a subset of subjects with ASD have been documented using positron emission tomography (PET). Brain regions with increased binding of a radiotracer to microglia included the cerebellum, midbrain, pons, fusiform gyri, and the anterior cingulate and orbitofrontal cortices 27 . Likewise, studies of postmortem brain tissue from individuals with schizophrenia also support the role of the immune system, including the activation of microglia. For example, a recent meta-analysis identified 41 studies reporting on 783 patients and 762 controls. They found convincing evidence of a significant increase in the density of microglia in the brains of schizophrenic patients compared with controls. This increase was most consistently observed in the temporal cortex 28 . Elevated levels of microglia immunoreactivity have also been reported in the cortex of depressed individuals, as well as in brain tissue from individuals who committed suicide 29, 30 . More recently, Setiawan et al. 31 reported evidence for microglia activation during major depressive episodes using positron emission tomography. These changes were significant in the prefrontal cortex, anterior cingulate cortex and insula. Greater microglia activation in the insula was correlated with the level of depressive symptom severity 31 .
In the case of TS and OCD, preliminary findings from studies of postmortem brain tissue and brain imaging studies also indicate that immune activation is present in some individuals with TS and childhood-onset OCD 21, 32 . More specifically, in the postmortem study, transcriptome data from the caudate nucleus and putamen from 9 TS and 9 matched control subjects identified 309 down-regulated and 822 up-regulated genes, in the patients with TS 21 . Using Weighted Gene Co-expression Network Analysis, 17 differentially expressed pathways or groups of genes were identified 33 . The power of this strategy is that it permits investigators to examine how genes and their products function in concert, rather than individually. The top-scoring down-regulated module was enriched for interneuron transcripts. However, the top-scoring up-regulated module was enriched with immune-related genes, associated with both the innate and adaptive immune systems. The pathway analyses pointed to the likely role of the microglia 20, 21 . A PET brain imaging study that used a radioligand associated with activation of the innate immune system, found evidence of microglia mediated neuroinflammation in the bilateral caudate nuclei in 12 children with TS. In this same PET study, neuroinflammation was also seen in the bilateral lentiform nucleus, as well as in the bilateral caudate nuclei, in 15 children diagnosed with PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections). Future studies are needed to confirm these findings 32 .
PANDAS was first described by Susan Swedo and her team at the National Institute of Mental Health in 1998 34 . The diagnostic criteria for PANDAS includes an abrupt "overnight" onset of OCD and other neuropsychiatric symptoms including tics, anxiety, emotional lability, enuresis, and attentional problems. The onset of PANDAS is in childhood. In some cases, these symptoms manifest a relapsing-remitting, episodic symptom course in the aftermath of an infection with group A beta-hemolytic streptococcal infections (GAS), as seen with Sydenham's chorea. PANDAS has been proposed to result from antibodies raised against GAS cross-reacting with brain antigens, based in part on molecular mimicry. However, the targets of these antibodies are not entirely clear and may be heterogeneous 35, 36 .
Currently, PANDAS remains a controversial topic 37 . Despite continued debates about the role of GAS infections in the etiopathogenesis of PANDAS, experts on both sides of the controversy agree that a subgroup of children with OCD have an unusually abrupt onset of symptoms, accompanied by a variety of comparably severe and acute neuropsychiatric symptoms. The acuity of symptom onset is the hallmark feature of their clinical presentation and is the basis for the name proposed for an expanded clinical entity: Pediatric Acute-onset Neuropsychiatric Syndrome (PANS). PANS does not require specific association with GAS and can be related to other infectious factors 38 . Modifying the PANDAS criteria to eliminate etiologic factors and to clarify the time-course of the initial clinical presentation is a step in the right direction, in our opinion.
However, in one recent study, serum was collected from children with well-characterized PANDAS (n = 5) who responded well to a course of intravenous gamma globulin (IVIG) and matched controls. The serum was then infused into the striatum of mice 39 . Antibodies from children with PANDAS bound to ∼80% of cholinergic interneurons, significantly higher than the <50% binding seen with matched healthy controls. Remarkably, after treatment with IVIG, symptom improvement resolved in parallel with a reversal of the elevated binding of antibodies to cholinergic interneurons 40 . Individuals with TS have fewer cholinergic interneurons in their striatum, based on the examination of postmortem brain tissue 41 . Future clarification of the functional consequences of this specific binding may provide new opportunities to identify and successfully intervene in children with PANDAS and PANS.
Genetic risk
The etiology of neurodevelopmental and neuropsychiatric disorders is complex and involves an individual's genetic background as well as exposure to a range of risk factors from conception onwards. For example, the high rates of heritability for ASD clearly indicate that genes play an important role in its etiology 42 . Over the past decade, a multitude of risk genes have been identified 43 . Their risk effects are highly variable, but many different variants converge on common biological pathways, including the immune system 44 . Intriguingly, some of these risk genes are located on Chromosome 6, which is densely packed with genes that code for immune molecules, particularly molecules within the major histocompatibility complex (HLA) 45 . These HLA genes code for cell-surface proteins that are responsible for the regulation of the immune system.
Studies of human brain tissue from individuals on the autism spectrum also implicate the involvement of the immune system. For example, transcriptomes from three cortical brain regions, BA10, BA14, and BA 44, from 104 subjects with ASD were sequenced. The pathway analyses from this large-scale RNA sequencing effort utilized regionmatched ASD and control brains, and strongly indicated that microglial genes are significantly dysregulated in these cortical regions. This analysis also highlights the interplay between innate immunity and neuronal activity in the etiology of ASD 25 . Similarly, a genome-wide methylation study of the prefrontal cortex found a significant enrichment for genomic regions responsible for immune function, specifically hypo-methylated CpGs 46, 47 . More recently, a weighted gene correlation network analysis detected 3 comethylation modules, which were significantly correlated with the ASD phenotype. These modules were enriched for genomic regions underlying neuronal, GABAergic, and immune system genes 48 .
The etiology of schizophrenia is also complex. Like ASD, there is a substantial body of data indicating that genetic factors, immune dysregulation and neuroinflammation are all involved in at least a subset of cases. Whole genome analyses have identified 108 conservatively defined loci that meet genome-wide significance 49, 50 . Many of these genes are highly expressed in the brain, as well as in immune function, including the HLA region on chromosome 6 51 . A more recent study completed a genome-wide expression analysis in peripheral blood mononuclear cells from U.S. veterans with schizophrenia (n = 52) and controls. A total of 167 differentially expressed genes were identified. Many of these genes were enriched primarily for pathways related to inflammatory mechanisms and immune cell trafficking 52 .
TS, OCD, and ADHD are also highly heritable conditions [53] [54] [55] [56] [57] [58] . Despite evidence for a substantial genetic contribution to disease risk, the identification and replication of genetic variants associated with these related conditions has been challenging. In the case of TS, the use of rare variant approaches has identified two genes of major effect. One is involved in synaptic development 59 and another is associated with histaminergic transmission 60 . Overall, GWAS studies for TS, OCD and ADHD have identified a large number of risk genes of minor effect, some of which impact immune function 61 . For example, a GWAS study (1,285 TS subjects and 4,964 controls) implicated several pathways related to specific astrocytic, oligodendrocytic and microglial activity, as well as to synaptic function 62 . More recently, Tylee et al. 50 re-examined the available GWAS data from individuals with TS, OCD, and ADHD and found significant genetic correlations between psychiatric and immune-related phenotypes based on genome-wide association data. These findings are also consistent with the findings of two large scale, populationbased, epidemiological studies from Denmark and Sweden, which have documented that some individuals with OCD, TS, and ADHD have an increased risk for developing an autoimmune disorder [63] [64] [65] . Conversely, Hounie et al. 66 some years earlier documented in a case-control study conducted in Brazil that a familial relationship exists between rheumatic fever (RF) and OCD-related disorders when considered in aggregate (OCD, subclinical OCD, TS, chronic tic disorders, transient tic disorders). If an individual has a family history of RF, then he/she is at greater risk of developing OCD and/or related disorders. The rate of these OCD-related conditions (ORC) among the first-degree relatives of rheumatic fever probands was significantly higher than the rate among the first-degree relatives of control subjects. The rate of these ORCs was highest among the first-degree relatives of rheumatic fever probands who also had an ORC. However, the rate of ORCs was also higher among the first-degree relatives of RF probands without an ORC, although the difference was not statistically significant 66 .
Stress, Neuroinflammation, Maternal Immune Activation, and the Neuro-immune Network Hypothesis
'Stress' includes multiple modalities that can be biological, social and/or psychological in character. Threatening physical or psychological stressors are sensed at many levels in the human body and the CNS. This information is then passed on to the hypothalamus after being processed by various limbic regions before it is communicated to the adrenal gland. This signaling pathway is evolutionarily conserved in mammalian species, and it is commonly referred to as the hypothalamic-pituitary-adrenal (HPA) axis. Activation of the HPA axis in response to stressful stimuli can, in turn, induce a variety of hormonal, immunological, cardiovascular and autonomic responses that impact multiple organ systems over the course of development 15 . Early-life adversity, sometimes referred to as 'toxic stress,' can amplify the crosstalk between the immune system and the neural circuits that encompass threat-related, reward-related, and executive control-related processes 67 . This crosstalk in the neuro-immune network can then, in turn, contribute to a number of somatic, neurodevelopmental and neuropsychiatric disorders 4, 68, 69 . Remarkably, in the case of mothers, stressful events occurring during a child's gestation can set the stage for adverse outcomes much later in the child's life 4, 15, 67, 68, 70, 71 . In the case of fathers, it also appears that stressful events occurring pre-conception can have an adverse long-term impact 72 .
Epidemiological studies provide compelling evidence that perturbations in the prenatal and perinatal environments are associated with an increased risk of offspring developing neuropsychiatric disorders including ASD 71,73-80 , schizophrenia 68, 71, [81] [82] [83] [84] [85] , mood and affective disorders 71,86-92 , OCD [93] [94] [95] , ADHD [96] [97] [98] , and TS [99] [100] [101] [102] . These studies have identified a number of factors that can contribute to an individual's risk of developing one or more of these disorders. They range from maternal infections, especially those associated with high fevers and a need for hospitalization 82 , inadequate nutrition 86, 87 as well as stressful life events occurring prenatally or during the first months of a child's life 88 .
In ASD, the link between pre-term birth and the emergence of ASD traits is well established 103 . There is also evidence supporting a link between immune system dysfunction and both pre-maturity and ASD 104 . Dozens of other environmental risk factors have been identified that impact the developing brain. The strongest evidence to date concerns Maternal Immune Activation (MIA). As noted above, multiple epidemiological studies implicate maternal infection and heightened levels of maternal stress during gestation and the perinatal period as risk factors for ASD 68, 70, [105] [106] [107] [108] [109] [110] . In a recent meta-analysis of 15 studies involving more than 40,000 cases of ASD, maternal infection during pregnancy was associated with an increased risk of ASD in the offspring. This was especially true for those requiring hospitalization. This risk was likely modulated by the individual's genetic background, the type of infectious agent, the time of the exposure, and the site of infection 79 . All of this points to the importance of the neuroimmune interface early in brain and somatic development 111 . There is also a growing body of data linking ASD with autoimmunity and allergies [112] [113] [114] . Wu et al. 113 conducted a meta-analysis of 11 studies that found that a family history of any autoimmune disorder was associated with a 28% higher risk of ASD in children. Several autoimmune disorders significantly contributed to this finding including hypothyroidism (OR=1.64), type 1 diabetes (OR=1.49), rheumatoid arthritis (OR=1.51), and psoriasis (OR=1.59). Another more recent study investigated maternal immune conditions during gestation, as well as the lifetime history of these conditions in family members. Logistic regression analyses included 663 children on the autism spectrum, 984 children with a developmental disability, and 915 controls. A maternal history of eczema/psoriasis and asthma was associated with a 20%-40% increased odds of both ASD and a developmental disability. In addition, children on the spectrum were also more likely to have had a history of psoriasis/eczema or allergies. No association was observed for paternal history of these immune conditions 112 . Interestingly, another recent study of a nationally representative sample of U.S. children (n = 199,520) found a significant association of a broad range of allergies (food, respiratory, and skin) with ASD 114 . In the immune-mediated subtype of ASD, it is possible that this association may impact the composition of an individual's microbiome which may affect the functioning of the 'gutbrain axis' 115 .
Finally, there have also been several studies examining the peripheral immune markers associated with ASD. For better or worse, the scientific literature is inconsistent in that no single marker has been found to be abnormal consistently across all of the studies [116] [117] [118] [119] [120] [121] . One of the most compelling studies was performed at University of California, Davis and involved an examination of neonatal blood spots from 214 children with ASD (141 severe, 73 mild/moderate), 27 children with developmental delays; and 62 typically developing children. Levels of 17 cytokines and chemokines were compared across groups and in relation to developmental and behavioral domains. The levels of Interleukin (IL)-1β & IL-4 in the neonatal blood specimens were independently associated with ASD. Elevated IL-4 was associated with the severe ASD phenotype and IL-1β was associated with the mild/moderate ASD phenotype. IL-4 was also negatively associated with nonverbal cognitive ability 122 . Fewer studies have examined the CNS directly, through the cerebrospinal fluid (CSF) or brain tissues. Vargas et al. 23 found increased levels of pro-inflammatory and immunomodulatory cytokines, differentially expressed across the cortical regions in postmortem samples from individuals with ASD (n = 11). In contrast, Pardo et al. 121 were able to track immune markers in the CSF longitudinally. They found striking differences in the expression of selected cytokines, immune-related growth factors, and chemokines that varied over time, when comparing ASD and neurotypical samples.
The environmental risk factors associated with an increased risk of developing schizophrenia include: advanced paternal age (>50 y.o. at birth), prenatal maternal malnutrition, prenatal infections (influenza), obstetrical complications and a low birth weight 85, [123] [124] [125] [126] . There is also a growing body of data linking schizophrenia with autoimmunity and allergies [127] [128] [129] .
Clinical and epidemiological studies have also explored a number of potential pre-and perinatal risk factors associated with the risk of developing OCD, TS and ADHD. These include inadequate or excessive maternal weight gain, maternal tobacco, alcohol and cannabis use, hyperemesis gravidarum, prolonged labor, preterm birth, and jaundice, as well as high levels of maternal depression and anxiety 93, [95] [96] [97] [98] [99] 101, 102, 130 . The findings vary from study to study and more work needs to be done before any firm conclusions can be reached concerning the possible role MIA may play in the pathogenesis of these disorders. In addition to these genetic and epidemiological findings, there is an emerging body of preliminary data that is focused on inflammatory markers (cytokine and immunoglobulin levels), immune cell populations, and gene expression profiling of peripheral lymphocytes. These data indicate some degree of hyperactivity of both the innate and the adaptive immune systems in TS, childhood-onset OCD and ADHD [131] [132] [133] [134] [135] .
The microbiome, perinatal nutrition and the 'gut-brain axis'
Aberrations in the microbiome after Maternal Immune Activation (MIA) can lead to altered development of peripheral immunity, both of which can alter brain development. Over the past two decades, the microbiome has emerged as an area of great scientific interest. Human microbiota includes bacteria, fungi, archaea and viruses 136 . As a species, our bodies contain many more non-human cells than human cells 137 . It is now clear from both animal models and human studies that the composition of an individual's microbiota has an impact on their health and wellbeing 138 . For example, developmentally, preclinical findings in animal models suggest that the gut microbiome plays a pivotal role in regulating microglial maturation and function and that this bidirectional crosstalk between the gut and the brain may influence disease pathogenesis 139 . Indeed, animal models have provided the most compelling evidence that gut bacteria and their metabolites play a role in CNS homeostasis and that they can directly affect behavior. Maternal and infant diet, stress, mode of delivery, e.g., vaginal vs. C-section, maternal infections, and antibiotic exposures all shape early microbial colonization patterns 140, 141 . How enduring these patterns are, and what, if any, long-term phenotypic impact they have on disease and neurodevelopment is currently being explored. Human studies have been primarily correlative in nature, so caution is warranted and must be applied before concluding that the composition of an individual's microbiota has a direct causal role in the pathogenesis of psychiatric disease.
Research on the microbiome of individuals with ASD is the most advanced 142, 143 and studies are now underway that are exploring the impact of microbiome transfer therapy 144 . Efforts to understand the role of the microbiome are also underway with regard to a number of other disorders including schizophrenia and bipolar disorder [145] [146] [147] [148] [149] [150] , TS, OCD, and related disorders including PANS and PANDAS [151] [152] [153] , major depression and mood disorders 154, 155 , alcohol use and eating disorders 156 , as well as neurodegenerative disorders 157 .
Another key mechanism concerns the "gut-brain axis." This axis involves the neural and molecular signaling that takes place between the gastrointestinal (GI) tract and the CNS [158] [159] [160] [161] . Not surprisingly, maternal stress, the HPA axis, the sympathetic and parasympathetic arms of the autonomic nervous system, as well as the individual's dietary intake and the composition of their microbiome all play an important role. The microbiota in the GI tract can influence CNS functions due to its ability to synthesize a wide range of molecules including neurotransmitters and their precursors, e.g., acetylcholine, gamma-aminobutyric acid (GABA), serotonin, catecholamines, melatonin, and histamine 158 . These interconnected systems are established shortly after birth and are influenced by a number of factors including: maternal psychosocial stress, infections, antimicrobial treatments, mode of delivery and obstetrical complications, as well as maternal and child dietary intake including breast feeding 130, 162 . Remarkably, there is now evidence from animal models and human studies that the 'microbiota-gut-brain axis' can influence gene expression and brain microstructure, as well as host stress-induced behavior, social interactions and learning and memory task performance [162] [163] [164] [165] [166] .
Another truly amazing finding is that bacteria appear to be present in both human (n=34) and mouse brains under noninfectious or nontraumatic conditions. These findings were presented as a poster at the Society for Neuroscience annual meeting in San Diego in November of 2018. The density of the bacteria varied by brain region, with abundant bacteria in the substantia nigra, hippocampus and prefrontal cortex. The observed bacteria were present in intracellular locations within astrocytes located near the blood brain barrier. They were also abundant adjacent to the blood brain barrier and within myelinated axons. RNA sequencing revealed that most of the bacteria were from three phyla common to the gut: Firmicutes, Proteobacteria, and Bacteroidetes 167 . If replicated, it will be important to examine postmortem tissue from individuals with neurodevelopmental and neuropsychiatric disorders to determine if gut microbiota are present and, if so, how they vary from disorder to disorder.
DISCUSSION
The combination of an individual's genetic background, autoimmune status and a range of other factors including MIA and an individual's 'microbiota-gut-brain axis' set the stage for the emergence of neurodevelopmental, neuropsychiatric, and neurodegenerative disorders. In some instances, "second hits" during childhood and adolescence, including stress and substance use, may be key factors as well. In this review we have briefly summarized the published data concerning the role of the immune system in the pathobiology of several neurodevelopmental and neuropsychiatric disorders including ASD and schizophrenia as well as OCD, ADHD and tic disorders. At present, the available data highlight the findings of epidemiological, genetic, and post-mortem studies, as well as, cross-sectional and longitudinal studies of immune activation in the periphery. We have also briefly summarized the results of studies that seek to characterize the microbiota associated with these disorders. We have reviewed the current state-of-the-art with regard to the therapeutic potential for immunomodulatory interventions for each of these conditions.
In closing, we highlight the value of animal model systems particularly with regard to embryonic development. Embryonic development captures a particularly complex period, in which genetic and environmental factors can interact to contribute to risk. In addition to clinical and epidemiological studies, this field of research has been driven by the use of animal model systems 9, 11, 140, [168] [169] [170] . For example, animal research has documented that inflammatory perturbations in the developing brain can divert microglia from their normal physiological role to a potentially more pathological role, both in the short-and long-term 11, 171, 172 . Maternal inflammation generally can increase microglial density and/or activation in the offspring brain 173 . These changes begin embryonically, as demonstrated by increased microglial density and reactivity a few days after the midor late-gestation administration of immuno-stimulatory compounds such as lipopolysaccharide (LPS), which mimic infections by gram-negative bacteria 174, 175 . LPS stimulates the production of many endogenous proinflammatory cytokines including interleukin-1b(IL-1b), IL-6, and tumor necrosis factor alpha (TNF-alpha), which, along with other factors, recruit, activate, and stimulate the production of immune cells [174] [175] [176] . Additionally, microglial and cytokine changes in the developing brain may directly influence synaptic plasticity as well as increase the reactivity of an animal's immune system to subsequent immune challenges in adulthood 7, 177, 178 .
It is also important to highlight the role of the placenta, as it plays a very significant role in prenatal immune-neurodevelopmental interactions. The placenta is highly immunologically specialized, and it can serve both as a conduit for and regulator of immune factor traffic at the maternal-fetal interface 177 . Animal models have also documented the transgenerational inheritance of behavioral and metabolic effects of paternal exposure to traumatic stress in early postnatal life 179 . In sum, differences certainly exist between rodents and humans that limit the value of animal model systems, with regard to a number of relevant variables including developmental timing in utero, placental morphology, hormone production, and immunoregulatory protein expression. However, the ability of animal model systems to posit causal mechanisms using experimental designs is an obvious strength 170, 177, 180 .
Some of the unanswered questions that are fundamental to this area of research include how and why the onset of specific neuropsychiatric disorders is often separated by years or decades from early developmental disruptions associated with MIA. Despite limitations, animal models provide critical data supporting prenatal inflammatory programming of the brain and will be fundamentally involved as immunome-level analyses and other innovative methods are developed. Hopefully, advances in developmental neuroscience that link prenatal events with subsequent brain-development events will provide a foundation on which the pathophysiology of various psychiatric disorders can be better understood and more adequately treated 144, 148, [181] [182] [183] [184] .
